Long-term effects of asparaginase-associated pancreatitis

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt

Standard

Long-term effects of asparaginase-associated pancreatitis. / Skipper, Mette Tiedemann; Albertsen, Birgitte Klug; Schmiegelow, Kjeld; Andrés-Jensen, Liv.

I: Pediatric Blood & Cancer, Bind 70, Nr. 9, e30528, 2023.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt

Harvard

Skipper, MT, Albertsen, BK, Schmiegelow, K & Andrés-Jensen, L 2023, 'Long-term effects of asparaginase-associated pancreatitis', Pediatric Blood & Cancer, bind 70, nr. 9, e30528. https://doi.org/10.1002/pbc.30528

APA

Skipper, M. T., Albertsen, B. K., Schmiegelow, K., & Andrés-Jensen, L. (2023). Long-term effects of asparaginase-associated pancreatitis. Pediatric Blood & Cancer, 70(9), [e30528]. https://doi.org/10.1002/pbc.30528

Vancouver

Skipper MT, Albertsen BK, Schmiegelow K, Andrés-Jensen L. Long-term effects of asparaginase-associated pancreatitis. Pediatric Blood & Cancer. 2023;70(9). e30528. https://doi.org/10.1002/pbc.30528

Author

Skipper, Mette Tiedemann ; Albertsen, Birgitte Klug ; Schmiegelow, Kjeld ; Andrés-Jensen, Liv. / Long-term effects of asparaginase-associated pancreatitis. I: Pediatric Blood & Cancer. 2023 ; Bind 70, Nr. 9.

Bibtex

@article{3722630deb6243938d62952d955714ce,

title = "Long-term effects of asparaginase-associated pancreatitis",

abstract = "Pancreatitis is a common and severe toxicity that occurs during asparaginase treatment for acute lymphoblastic leukemia, and has received increasing attention during the last decades. However, no consensus regarding follow-up exists. In this commentary, we highlight potential long-term health-related effects following asparaginase-associated pancreatitis, thereby providing clinicians with a framework when following these patients during and after cessation of therapy.",

keywords = "ALL, chemotherapy, late effects of cancer treatment, long-term survival, pediatric hematology/oncology",

author = "Skipper, {Mette Tiedemann} and Albertsen, {Birgitte Klug} and Kjeld Schmiegelow and Liv Andr{\'e}s-Jensen",

note = "Publisher Copyright: {\textcopyright} 2023 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals LLC.",

year = "2023",

doi = "10.1002/pbc.30528",

language = "English",

volume = "70",

journal = "Pediatric Blood & Cancer",

issn = "1545-5009",

publisher = "JohnWiley & Sons, Inc.",

number = "9",

}

RIS

TY - JOUR

T1 - Long-term effects of asparaginase-associated pancreatitis

AU - Skipper, Mette Tiedemann

AU - Albertsen, Birgitte Klug

AU - Schmiegelow, Kjeld

AU - Andrés-Jensen, Liv

PY - 2023

Y1 - 2023

N2 - Pancreatitis is a common and severe toxicity that occurs during asparaginase treatment for acute lymphoblastic leukemia, and has received increasing attention during the last decades. However, no consensus regarding follow-up exists. In this commentary, we highlight potential long-term health-related effects following asparaginase-associated pancreatitis, thereby providing clinicians with a framework when following these patients during and after cessation of therapy.

AB - Pancreatitis is a common and severe toxicity that occurs during asparaginase treatment for acute lymphoblastic leukemia, and has received increasing attention during the last decades. However, no consensus regarding follow-up exists. In this commentary, we highlight potential long-term health-related effects following asparaginase-associated pancreatitis, thereby providing clinicians with a framework when following these patients during and after cessation of therapy.

KW - ALL

KW - chemotherapy

KW - late effects of cancer treatment

KW - long-term survival

KW - pediatric hematology/oncology

U2 - 10.1002/pbc.30528

DO - 10.1002/pbc.30528

M3 - Comment/debate

C2 - 37376950

AN - SCOPUS:85163303452

VL - 70

JO - Pediatric Blood & Cancer

JF - Pediatric Blood & Cancer

SN - 1545-5009

IS - 9

M1 - e30528

ER -

ID: 368805894